Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 … – PharmaLive.com (press release)
Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 …PharmaLive.com (press release)In the study of 111 heart failure patients with chronic kidney disease, CLP1001 demonstrated improvement in heart failure symptoms as compared…